… of updated Practice Recommendations for HCT and CAR-T Therapy and the second edition of the EU CAR T-cell Handbook reaffirmed our leadership in harmonising …

… is promising, although under investigation. Application of CAR-T regs in autoimmune diseases - Matteo Doglio Matteo Doglio gave updates on ongoing studies for CAR-T regs in SLE, a very promising and rapidly evolving …

… with drug shortages as well as recent developments in CAR-T in BiTE therapies.  We are confident that the programme …

… Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, …

… and set limits. With the new treatment of CAR-T and other therapies, and the ever-growing requests for … because this delay means that the proper forms for CAR-T / IEC were not developed in PROMISE, and now we are …

… the privilege of presenting two first-author posters on CAR-T therapy and bispecific antibodies in lymphoma, and one of … advances in hematopoietic stem cell transplantation and CAR-T therapy. The scientific sessions were not only …

… and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma … infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy Kitsada Wudhikarn & Miguel-Angel Perales Get …

… the pick of our recent most highly cited articles? Non-T depleted haploidentical stem cell transplantation in AML … Toshiyuki Ueno et al. Efficacy and safety of CAR-T cell therapy in minorities Astha Thakkar et al. Chimerism …

… transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: … a real-world experience Marta Castelli et al   Anti-T-lymphocyte globulin improves GvHD-free and relapse-free …

… Accès national et besoins en thérapie CAR-T CD19 dans la région Euro …